Literature DB >> 34676024

Dual Inhibition of KRAS G12C and G12D Mutants as a Potential Treatment in Cancer Therapy.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2021        PMID： 34676024      PMCID： PMC8521615          DOI： 10.1021/acsmedchemlett.1c00441

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

Review 1.  Drugging "undruggable" genes for cancer treatment: Are we making progress?

Authors:  Michael J Duffy; John Crown
Journal:  Int J Cancer       Date:  2020-08-07       Impact factor: 7.396

2.  Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics.

Authors:  Hao Chen; Jeff B Smaill; Tongzheng Liu; Ke Ding; Xiaoyun Lu
Journal:  J Med Chem       Date:  2020-11-23       Impact factor: 7.446

Review 3.  RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients.

Authors:  Umberto Malapelle; Francesco Passiglia; Chiara Cremolini; Maria Lucia Reale; Francesco Pepe; Pasquale Pisapia; Antonio Avallone; Diego Cortinovis; Alfonso De Stefano; Matteo Fassan; Gabriella Fontanini; Domenico Galetta; Calogero Lauricella; Angela Listì; Fotios Loupakis; Fabio Pagni; Filippo Pietrantonio; Sara Pilotto; Luisella Righi; Andrea Sartore Bianchi; Hector Soto Parra; Marcello Tiseo; Michela Verzè; Giancarlo Troncone; Silvia Novello
Journal:  Eur J Cancer       Date:  2021-02-12       Impact factor: 9.162

Review 4.  Mechanisms of Resistance to KRASG12C-Targeted Therapy.

Authors:  Neal S Akhave; Amadeo B Biter; David S Hong
Journal:  Cancer Discov       Date:  2021-04-05       Impact factor: 39.397

Review 5.  Autophagy as a therapeutic target in pancreatic cancer.

Authors:  Max Piffoux; Erwan Eriau; Philippe A Cassier
Journal:  Br J Cancer       Date:  2020-09-15       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.